IBDEI38L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,54400,0)
 ;;=L56.3^^256^2764^268
 ;;^UTILITY(U,$J,358.3,54400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54400,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,54400,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,54400,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,54401,0)
 ;;=L57.0^^256^2764^12
 ;;^UTILITY(U,$J,358.3,54401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54401,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,54401,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,54401,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,54402,0)
 ;;=L60.0^^256^2764^161
 ;;^UTILITY(U,$J,358.3,54402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54402,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,54402,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,54402,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,54403,0)
 ;;=L60.1^^256^2764^234
 ;;^UTILITY(U,$J,358.3,54403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54403,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,54403,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,54403,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,54404,0)
 ;;=L60.2^^256^2764^233
 ;;^UTILITY(U,$J,358.3,54404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54404,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,54404,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,54404,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,54405,0)
 ;;=L60.3^^256^2764^170
 ;;^UTILITY(U,$J,358.3,54405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54405,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,54405,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,54405,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,54406,0)
 ;;=L60.4^^256^2764^88
 ;;^UTILITY(U,$J,358.3,54406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54406,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,54406,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,54406,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,54407,0)
 ;;=L60.5^^256^2764^290
 ;;^UTILITY(U,$J,358.3,54407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54407,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,54407,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,54407,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,54408,0)
 ;;=L60.8^^256^2764^168
 ;;^UTILITY(U,$J,358.3,54408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54408,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,54408,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,54408,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,54409,0)
 ;;=L62.^^256^2764^169
 ;;^UTILITY(U,$J,358.3,54409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54409,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,54409,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,54409,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,54410,0)
 ;;=L64.9^^256^2764^33
 ;;^UTILITY(U,$J,358.3,54410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54410,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,54410,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,54410,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,54411,0)
 ;;=L65.9^^256^2764^231
 ;;^UTILITY(U,$J,358.3,54411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54411,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,54411,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,54411,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,54412,0)
 ;;=L70.0^^256^2764^6
 ;;^UTILITY(U,$J,358.3,54412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54412,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,54412,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,54412,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,54413,0)
 ;;=L70.1^^256^2764^1
 ;;^UTILITY(U,$J,358.3,54413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54413,1,3,0)
 ;;=3^Acne Conglobata
